DexCom, Inc. (DXCM)
73.78
+0.35
(+0.48%)
USD |
NASDAQ |
Mar 02, 16:00
73.48
-0.30
(-0.41%)
After-Hours: 20:00
DexCom Shareholders Equity (Quarterly) : 2.746B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 371.89M |
| Abbott Laboratories | 52.13B |
| Insulet Corp. | 1.515B |
| Krystal Biotech, Inc. | 1.220B |
| Boston Scientific Corp. | 24.23B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.340B |
| Total Liabilities (Quarterly) | 3.594B |
| Debt to Equity Ratio | 0.5061 |
| Current Ratio | 1.882 |
| Net Debt Paydown Yield | 0.94% |